| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Third universal definition of myocardial infarction | Nature Reviews Cardiology | 2012 | 2,676 |
| 2 | COVID-19 and the cardiovascular system | Nature Reviews Cardiology | 2020 | 2,594 |
| 3 | Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty | Nature Reviews Cardiology | 2018 | 1,988 |
| 4 | Epidemiology and risk profile of heart failure | Nature Reviews Cardiology | 2011 | 1,661 |
| 5 | Epidemiology and aetiology of heart failure | Nature Reviews Cardiology | 2016 | 1,284 |
| 6 | The inflammatory response in myocardial injury, repair, and remodelling | Nature Reviews Cardiology | 2014 | 1,164 |
| 7 | COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives | Nature Reviews Cardiology | 2020 | 1,066 |
| 8 | Mechanisms of physiological and pathological cardiac hypertrophy | Nature Reviews Cardiology | 2018 | 1,027 |
| 9 | Stress and cardiovascular disease | Nature Reviews Cardiology | 2012 | 989 |
| 10 | Epidemiology of heart failure with preserved ejection fraction | Nature Reviews Cardiology | 2017 | 983 |
| 11 | Epidemiology of venous thromboembolism | Nature Reviews Cardiology | 2015 | 838 |
| 12 | Dilated cardiomyopathy: the complexity of a diverse genetic architecture | Nature Reviews Cardiology | 2013 | 804 |
| 13 | Obesity, inflammation, and atherosclerosis | Nature Reviews Cardiology | 2009 | 799 |
| 14 | Epidemiology of cardiovascular disease in China: current features and implications | Nature Reviews Cardiology | 2019 | 784 |
| 15 | Monocytes in atherosclerosis: subsets and functions | Nature Reviews Cardiology | 2010 | 767 |
| 16 | Inflammation and the pathogenesis of atrial fibrillation | Nature Reviews Cardiology | 2015 | 749 |
| 17 | Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities | Nature Reviews Cardiology | 2019 | 724 |
| 18 | Vascular smooth muscle cells in atherosclerosis | Nature Reviews Cardiology | 2019 | 701 |
| 19 | Effects of stress on the development and progression of cardiovascular disease | Nature Reviews Cardiology | 2018 | 700 |
| 20 | Assessment and management of blood-pressure variability | Nature Reviews Cardiology | 2013 | 675 |
| 21 | Myocarditis and inflammatory cardiomyopathy: current evidence and future directions | Nature Reviews Cardiology | 2021 | 671 |
| 22 | Myocardial ischaemia–reperfusion injury and cardioprotection in perspective | Nature Reviews Cardiology | 2020 | 661 |
| 23 | Pathophysiology and epidemiology of abdominal aortic aneurysms | Nature Reviews Cardiology | 2011 | 659 |
| 24 | Mechanisms of disease: pulmonary arterial hypertension | Nature Reviews Cardiology | 2011 | 635 |
| 25 | Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension | Nature Reviews Cardiology | 2021 | 635 |
| 26 | Myocardial remodeling after infarction: the role of myofibroblasts | Nature Reviews Cardiology | 2010 | 632 |
| 27 | Platelet biology and functions: new concepts and clinical perspectives | Nature Reviews Cardiology | 2019 | 630 |
| 28 | World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline | Nature Reviews Cardiology | 2012 | 629 |
| 29 | Global epidemiology of atrial fibrillation | Nature Reviews Cardiology | 2014 | 602 |
| 30 | The changing epidemiology of congenital heart disease | Nature Reviews Cardiology | 2011 | 589 |
| 31 | Dysfunctional HDL and atherosclerotic cardiovascular disease | Nature Reviews Cardiology | 2016 | 576 |
| 32 | Epidemiology of valvular heart disease in the adult | Nature Reviews Cardiology | 2011 | 571 |
| 33 | Mitochondrial function as a therapeutic target in heart failure | Nature Reviews Cardiology | 2017 | 563 |
| 34 | Myofibroblast-mediated mechanisms of pathological remodelling of the heart | Nature Reviews Cardiology | 2013 | 555 |
| 35 | The pathophysiology of heart failure with preserved ejection fraction | Nature Reviews Cardiology | 2014 | 537 |
| 36 | Macrophage subsets in atherosclerosis | Nature Reviews Cardiology | 2015 | 528 |
| 37 | HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms | Nature Reviews Cardiology | 2011 | 517 |
| 38 | The NLRP3 inflammasome in acute myocardial infarction | Nature Reviews Cardiology | 2018 | 513 |
| 39 | Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors | Nature Reviews Cardiology | 2018 | 504 |
| 40 | Nitric oxide signalling in cardiovascular health and disease | Nature Reviews Cardiology | 2018 | 502 |
| 41 | Epidemiological studies of CHD and the evolution of preventive cardiology | Nature Reviews Cardiology | 2014 | 499 |
| 42 | Peripheral artery disease: epidemiology and global perspectives | Nature Reviews Cardiology | 2017 | 495 |
| 43 | Dietary metabolism, the gut microbiome, and heart failure | Nature Reviews Cardiology | 2019 | 495 |
| 44 | Mendelian randomization in cardiometabolic disease: challenges in evaluating causality | Nature Reviews Cardiology | 2017 | 489 |
| 45 | Regulatory mechanisms in vascular calcification | Nature Reviews Cardiology | 2010 | 487 |
| 46 | Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine | Nature Reviews Cardiology | 2020 | 481 |
| 47 | Thyroid hormones and cardiovascular disease | Nature Reviews Cardiology | 2017 | 475 |
| 48 | Viral myocarditis—diagnosis, treatment options, and current controversies | Nature Reviews Cardiology | 2015 | 465 |
| 49 | The ABC pathway: an integrated approach to improve AF management | Nature Reviews Cardiology | 2017 | 463 |
| 50 | Role of gut microbiota in atherosclerosis | Nature Reviews Cardiology | 2017 | 459 |
